Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, Wisconsin 53792, USA.
Endocr Pract. 2012 Sep-Oct;18(5):720-6. doi: 10.4158/EP12014.OR.
To determine whether laparoscopic adrenalectomy in patients without radiologic evidence of cancer compromises the perioperative and long-term outcomes in patients with large (≥ 6 cm) pheochromocytomas.
We analyzed a prospective adrenal database of consecutive patients who underwent adrenalectomy at our institution between September 2000 and September 2010. Patients with diagnosed pheochromocytoma who underwent laparoscopic adrenalectomy were included. Patients with tumors smaller than 6 cm were compared with those presenting with tumors 6 cm or larger.
One hundred fifty-seven patients underwent adrenalectomy, and there were 32 catecholamine-secreting tumors. Of the 33, 7 were excluded from the study because of open surgery. Thus, 25 patients presented with 26 pheochromocytomas and underwent laparoscopic adrenalectomy. Thirteen of the 25 patients (52%) were women. Mean age (± standard error of the mean) was 53 ± 3 years. Mean tumor size was 5.2 ± 0.5 cm, and 11 pheochromocytomas (42%) were 6 cm or larger. Tumor size was significantly different between the large pheochromocytoma and the small pheochromocytoma groups (7.6 ± 0.4 vs 3.6 ± 0.4 cm, P<.001), but there was no significant difference in intraoperative complications, estimated blood loss, cancer diagnosis, or recurrence. The length of stay was comparable between the 2 cohorts, and there were no incidents of capsular invasion or adverse cardiovascular events.
Laparoscopic adrenalectomy of pheochromocytomas larger than 6 cm is feasible and safe with comparable results to those achieved with laparoscopic adrenalectomy in patients with smaller pheochromocytomas.
确定在没有癌症影像学证据的患者中进行腹腔镜肾上腺切除术是否会影响大(≥6cm)嗜铬细胞瘤患者的围手术期和长期结果。
我们分析了 2000 年 9 月至 2010 年 9 月期间在我院接受肾上腺切除术的连续患者的前瞻性肾上腺数据库。纳入接受腹腔镜肾上腺切除术的诊断为嗜铬细胞瘤的患者。将肿瘤小于 6cm 的患者与肿瘤为 6cm 或更大的患者进行比较。
157 例患者接受了肾上腺切除术,其中有 32 例儿茶酚胺分泌肿瘤。在这 33 例中,有 7 例因开放性手术而被排除在研究之外。因此,有 25 例患者出现 26 例嗜铬细胞瘤并接受了腹腔镜肾上腺切除术。25 例患者中有 13 例(52%)为女性。平均年龄(±标准误差)为 53±3 岁。平均肿瘤大小为 5.2±0.5cm,11 例嗜铬细胞瘤(42%)为 6cm 或更大。大嗜铬细胞瘤和小嗜铬细胞瘤组的肿瘤大小差异显著(7.6±0.4 与 3.6±0.4cm,P<.001),但术中并发症、估计出血量、癌症诊断或复发无显著差异。两组的住院时间相似,且无包膜侵犯或不良心血管事件发生。
对于大于 6cm 的嗜铬细胞瘤,腹腔镜肾上腺切除术是可行和安全的,与腹腔镜肾上腺切除术治疗较小嗜铬细胞瘤的结果相当。